## Diagnosis of Immediate Hypersensitivity Reactions (Type I ADR) ### Clinical Context The patient presents with anaphylaxis (immediate-onset, within 15 minutes of drug exposure). This is a **Type I hypersensitivity** adverse drug reaction mediated by IgE-mast cell degranulation. ### Investigation of Choice: Serum Tryptase **Key Point:** Serum tryptase is the gold standard acute-phase marker for mast cell degranulation and anaphylaxis diagnosis. - **Timing:** Must be drawn within **15–30 minutes** of symptom onset (peak levels) - **Mechanism:** Tryptase is a preformed enzyme released from mast cell granules during degranulation - **Sensitivity & Specificity:** ~90% sensitive for anaphylaxis when drawn in the acute window - **Advantage:** Objective, quantitative, and independent of clinical assessment variability **High-Yield:** Serum tryptase ≥11.4 ng/mL (or >20% above baseline) within 15–30 min strongly supports anaphylaxis diagnosis. ### Why This Timing Matters | Investigation | Optimal Timing | Sensitivity in Anaphylaxis | Clinical Use | |---|---|---|---| | **Serum tryptase** | 15–30 min post-onset | ~90% | Acute confirmation | | **Skin prick test** | ≥2–4 weeks later | ~70–80% | Allergen identification (delayed) | | **Intradermal test** | ≥2–4 weeks later | Variable, risk of re-reaction | Confirmatory (delayed) | | **RAST/Specific IgE** | Any time | ~60–70% | Supportive (not acute) | **Clinical Pearl:** Skin testing and RAST are performed **after acute phase resolution** (2–4 weeks) to avoid re-triggering anaphylaxis and to allow IgE levels to stabilize. ### Why Serum Tryptase is Superior in Acute Setting 1. **Immediate availability:** Can be sent stat from bedside 2. **No risk of re-reaction:** Non-provocative, in vitro test 3. **Objective marker:** Not dependent on observer bias 4. **Diagnostic window:** Acute elevation is pathognomonic for mast cell activation **Mnemonic:** **TRYPTASE = T (Timing critical), R (Rapid mast cell marker), Y (Yes to anaphylaxis), P (Peak 15–30 min), T (Type I hypersensitivity), A (Acute phase only), S (Specific for degranulation), E (Elevated ≥11.4 ng/mL)** ### Post-Acute Confirmation (After 2–4 Weeks) Once the acute phase resolves, skin prick testing or RAST can identify the specific penicillin determinant responsible for sensitization.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.